Izradu sajta pomogla je farmaceutska kompanija Janssen Pharmaceutical Companies of Johnson&Johnson. Izrada sajta agencija Blink N
SRP / ENG


ETIOPATOGENEZA SHIZOFRENIJE


Maric NP, Svrakic DM (2012). Why schizophrenia genetics needs epigenetics: a review. Psychiatr Danub 24 (1): 2-18.

Ivković M, Zamurović L, Jovanović A, Dobričić V, Damjanović A, Savić-Pavićević D, Romac S (2011). Retinoic acid induced 1 gene and clinical subtypes of schizophrenia: an association study. Psychiatry Res 188(2): 297-8.

Branković A, Marić NP (2010). Duration of untreated psychosis: The definition, the description and relation to the illness outcome. Engrami 32: 35-44

Marić NP, Jašović-Gašić M (2010). Early intervention in psychosis: Concept, present situation and perspective. Engrami 32: 5-17.

Ilić I, Marić NP, Šaula-Marojević B, Pavić S, Kolašinac Z, Mijović A (2010). Intensified explortory work with adolescents and young adults: A possibility of early detection of psychotic disorders. Engrami 32: 19-34.

Kecmanović M, Dobricić V, Dimitrijević R, Keckarević D, Savić-Pavićević D, Keckarević-Marković M, Ivkovic M, Romac S (2010). Schizophrenia and apolipoprotein E gene polymorphism in Serbian population. Int J Neurosci 120(7): 502-6.

Maric N, Jasovic Gasić M (2010). Rane intervencije u psihozama:concept, sadasnje stanje i perspektive. Engrami 32 (4): 5-17.

Cvetić T, Vuković O, Britvić D, Ivković M, Dukić-Dejanović S, Lecić-Tosevski D (2009). Comparative analysis of soft neurological signs in positive and negative subtype of schizophrenia. Psychiatr Danub 21(2): 174-8.

Petronijević ND, Radonjić NV, Ivković MD, Marinković D, Piperski VD, Duricić BM, Paunović VR (2008). Plasma homocysteine levels in young male patients in the exacerbation and remission phase of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 32(8): 1921-6.

Pantović M, Milošević M, Marić NP, Britvić D, Vuković O, Jašović-Gašić M (2008). Katatoni sindrom - savremena razmatranja. Engrami 30(3-4): 93-102.

Latković O, Stojiljković D, Kurtanović B, Ilić K, Marić N (2008). Redosled rođenja i rizik za shizofreniju i depresiju. Engrami 30(2): 5-13.

Schneider-Axmann T, Kamer T, Moroni M, Maric N, Tepest R, Dani I, Honer WG, Scherk H, Rietschel M, Schulze TG, Muller DJ, Cordes J, Schonell H, Steinmetz H, Gaebel W, Vogeley K, Kuhn KU, Wagner M, Maier W, Traber F, Block W, Schild HH, Falkai P (2006). Relation between cerebrospinal fluid, gray matter and white matter changes in families with schizophrenia. J Psychiatr Res 40: 646-55.

Maric N, Myin-Germeys I, Delespaul P, de Graaf R, Vollebergh W, Van Os J (2004). Is our concept of schizophrenia influenced by Berkson's bias? Soc Psychiatry Psychiatr Epidemiol 39: 600-5.

Branković SB, Paunović VR (2004). Razvojni model patogeneze i vulnerabilnost – stres model toka shizofrenije. U: VR Paunović (urednik), Shizofrenija na razmeđu milenijuma. Medicinski fakultet, Beograd, str. 75-87.

Ivković M, Damjanović A, Paunović VR (2003). [Correlation of neurodevelopmental disorders in schizophrenia]. Srp Arh Celok Lek. 131(7-8): 294-9.

Maric N, Krabbendam L, VolleberghW , de Graaf R, van Os J (2003). Sex differences in symptoms of psychosis in a non-selected, general population sample. Schizophr Res 63: 89-95.

Marić N, Kamer T., Schnaider Axman T, Dani I, Jasović Gasić M, Paunović V, Falkai P (2003). Volumetrijska analiza sive mase, bele mase i prostora cerebrospinalne tečnosti. Srp Arh Celok Lek. 131: 26-30.